In contrast, in p53-deficient GBM-SCs, FoxO1 and FoxO3 were not required for self-renewal and post-treatment survival, suggesting that these functions can be maintained through the loss of DNA damage-responsive p53 instead (Figure 7). This evidence concerns the gene TP53 and glioblastoma.